Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bancorp, Inc.TBBK · Entity 4314 | Director | May 27, 2026 | May 28, 2026 |
| UNISYS CORPUIS · Entity 6360 | SVP & CTO | May 03, 2024 | May 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bancorp, Inc.
Report date May 27, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,663 |
Reported balance
After 2026-05-27 transaction · row 1
1 source rowRow 1 · 2026-05-27 · Grant · Acquired 2,250 · Balance 4,663 F1: The Reporting Person was granted restricted stock units, each of which represents the right to receive one share of common stock of The Bancorp, Inc. upon vesting. The restricted stock units shall vest in full one year from the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units, each of which represents the right to receive one share of common stock of The Bancorp, Inc. upon vesting. The restricted stock units shall vest in full one year from the date of grant.
UNISYS CORP
Report date May 03, 2024 · Filed May 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,186 |
Ending reported balance
After 2024-05-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-05-03 · Tax withholding · Disposed 325 · Balance 63,276 Row 2 · 2024-05-03 · Tax withholding · Disposed 1,090 · Balance 62,186 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CROSS COUNTRY HEALTHCARE INC
Report date July 21, 2026 · Filed July 21, 2026
Section 16 reporting ended · disclosed 2026-07-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-07-21 transaction · row 1
1 source rowRow 1 · 2026-07-21 · Disposition to issuer · Disposed 31,289 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2) F2: at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2)
F2: at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 21, 2026 Filed Jul 21, 2026 20:08 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Disposition to issuerCommon Stock | 31,289 | $13.25 | $414,579.25 |
DisclosureSEC source: 0001012975-26-000688 · form4.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2) F2 · kind: at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration. Read SEC document |
| May 27, 2026 Filed May 28, 2026 22:54 UTC | Bancorp, Inc. TBBK · Entity 4314 | GrantCommon Stock | 2,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002039852-26-000085 · ownership.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,663 F1 · price: The Reporting Person was granted restricted stock units, each of which represents the right to receive one share of common stock of The Bancorp, Inc. upon vesting. The restricted stock units shall vest in full one year from the date of grant. Read SEC document |
| December 18, 2025 Filed Dec 22, 2025 12:22 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 18,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-25-000961 · form4.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,289 F1 · shares: These restricted shares of common stock ("RSAs") will vest on December 18. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 13:28 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock | 2,182 | $13.18 | $28,758.76 |
DisclosureSEC source: 0001062993-25-010757 · form4.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,609 F1 · shares: These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on June 1, 2025. Read SEC document |
| May 28, 2025 Filed May 30, 2025 20:07 UTC | Bancorp, Inc. TBBK · Entity 4314 | GrantCommon Stock | 2,413 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002039852-25-000091 · ownership.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,413 F1 · price: The Reporting Person was granted restricted stock units, each of which represents the right to receive one share of common stock of The Bancorp, Inc. upon vesting. The restricted stock units shall vest in full one year from the date of grant. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:17 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock | 2,150 | $15.12 | $32,508.00 |
DisclosureSEC source: 0001062993-24-011806 · form4.xml · nonDerivative · entry 2 Allen Dwayne · CIK 0001857647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,791 F2 · shares: These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on June 1, 2024. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:17 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 9,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-011806 · form4.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,941 F1 · shares: These restricted shares of common stock will vest on June 1, 2025. Read SEC document |
| May 03, 2024 Filed May 7, 2024 20:12 UTC | UNISYS CORP UIS · Entity 6360 | Tax withholdingCommon Stock | 1,090 | $5.08 | $5,537.20 |
DisclosureSEC source: 0001062993-24-009525 · form4.xml · nonDerivative · entry 2 Allen Dwayne · CIK 0001857647 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,186 Read SEC document |
| May 03, 2024 Filed May 7, 2024 20:12 UTC | UNISYS CORP UIS · Entity 6360 | Tax withholdingCommon Stock | 325 | $5.08 | $1,651.00 |
DisclosureSEC source: 0001062993-24-009525 · form4.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,276 Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 02:26 UTC | UNISYS CORP UIS · Entity 6360 | Tax withholdingCommon Stock | 3,052 | $5.28 | $16,114.56 |
DisclosureSEC source: 0001062993-24-005019 · form4.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,601 Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:36 UTC | UNISYS CORP UIS · Entity 6360 | GrantCommon Stock | 24,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004582 · form4.xml · nonDerivative · entry 3 Allen Dwayne · CIK 0001857647 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,653 Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 21:36 UTC | UNISYS CORP UIS · Entity 6360 | Tax withholdingCommon Stock | 567 | $5.25 | $2,976.75 |
DisclosureSEC source: 0001062993-24-004582 · form4.xml · nonDerivative · entry 2 Allen Dwayne · CIK 0001857647 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,629 Read SEC document |
| February 12, 2024 Filed Feb 15, 2024 00:00 UTC | UNISYS CORP UIS · Entity 6360 | GrantCommon Stock | 4,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-003214 · form4.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · SVP & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,453 F1 · shares: Represents shares earned with respect to the 2023 performance period pursuant to performance-based restricted stock units ("PB-RSUs") granted on February 28, 2023 under the Unisys Corporation 2023 Long-Term Incentive and Equity Compensation Plan. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 20:05 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Tax withholdingCommon Stock | 708 | $22.75 | $16,107.00 |
DisclosureSEC source: 0001062993-24-000535 · form4.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,020 F1 · shares: These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on January 3, 2024. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:12 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 5,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012934 · form4.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,728 F1 · shares: These restricted shares of common stock will vest on June 1, 2024. Read SEC document |
| May 03, 2023 Filed May 4, 2023 14:59 UTC | UNISYS CORP UIS · Entity 6360 | Exercise / conversionRestricted Stock Units · Derivative | 1,337 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-23-000035 · primary_doc.xml · derivative · entry 3 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,337 Underlying: Common Stock · 1,337 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Unisys Corporation common stock. F2 · derivative.exercise_date: Time-based restricted stock units ("TB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on May 3, 2022, 2023 and 2024, respectively (or is such date does not fall on a trading day, the immediately preceding trading day). F2 · derivative.expiration_date: Time-based restricted stock units ("TB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on May 3, 2022, 2023 and 2024, respectively (or is such date does not fall on a trading day, the immediately preceding trading day). Read SEC document |
| May 03, 2023 Filed May 4, 2023 14:59 UTC | UNISYS CORP UIS · Entity 6360 | Tax withholdingCommon Stock | 325 | $4.25 | $1,381.25 |
DisclosureSEC source: 0001857647-23-000035 · primary_doc.xml · nonDerivative · entry 2 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,281 Read SEC document |
| May 03, 2023 Filed May 4, 2023 14:59 UTC | UNISYS CORP UIS · Entity 6360 | Exercise / conversionCommon Stock | 1,337 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-23-000035 · primary_doc.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,606 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 23:00 UTC | UNISYS CORP UIS · Entity 6360 | GrantRestricted Stock Units · Derivative | 25,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-23-000025 · primary_doc.xml · derivative · entry 1 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,100 Underlying: Common Stock · 25,100 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Unisys Corporation common stock. F2 · derivative.exercise_date: Time-based restricted stock units ("TB-RSUs") granted on February 28, 2023 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on February 28, 2024, 2025 and 2026, respectively (or if such date does not fall on a trading day, the immediately preceding trading day). F2 · derivative.expiration_date: Time-based restricted stock units ("TB-RSUs") granted on February 28, 2023 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on February 28, 2024, 2025 and 2026, respectively (or if such date does not fall on a trading day, the immediately preceding trading day). Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 16:41 UTC | UNISYS CORP UIS · Entity 6360 | Exercise / conversionRestricted Stock Units · Derivative | 1,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-23-000011 · primary_doc.xml · derivative · entry 3 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,914 Underlying: Common Stock · 1,914 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Unisys Corporation common stock. F2 · derivative.exercise_date: Time-based restricted stock units ("TB-RSUs") granted on February 25, 2022 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on February 25, 2023, 2024 and 2025, respectively (or if such date does not fall on a trading day, the immediately preceding trading day). F2 · derivative.expiration_date: Time-based restricted stock units ("TB-RSUs") granted on February 25, 2022 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on February 25, 2023, 2024 and 2025, respectively (or if such date does not fall on a trading day, the immediately preceding trading day). Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 16:41 UTC | UNISYS CORP UIS · Entity 6360 | Tax withholdingCommon Stock | 567 | $5.20 | $2,948.40 |
DisclosureSEC source: 0001857647-23-000011 · primary_doc.xml · nonDerivative · entry 2 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,269 Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 16:41 UTC | UNISYS CORP UIS · Entity 6360 | Exercise / conversionCommon Stock | 1,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-23-000011 · primary_doc.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:23 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 1,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-000496 · form4.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,916 F1 · shares: These restricted shares of common stock will vest on January 3, 2024. Read SEC document |
| May 03, 2022 Filed May 5, 2022 13:45 UTC | UNISYS CORP UIS · Entity 6360 | Exercise / conversionRestricted Stock Units · Derivative | 1,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-22-000030 · primary_doc.xml · derivative · entry 6 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,203 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 0.9000 shares of Unisys Corporation common stock. F4 · derivative.exercise_date: Performance-based restricted stock units ("PB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The PB-RSUs are eligible to be earned in equal annual amounts over a three year period based on Unisys Corporation's relative total shareholder return compared to the Russell 2000 Index from January 1, 2021 through December 31, 2021, 2022 and 2023, respectively, and then such PB-RSUs vest on the later of May 3, 2021, 2022 and 2023, respectively (or is such date does not fall on a trading day, the immediately preceding trading day), and the date on which the Board of Directors verifies the vesting of the applicable tranche of the PB-RSU grant to Unisys Corporation's Chief Executive Officer. This report only relates to the PB-RSUs the reporting person earned during the 2021 performance period. All shares resulting from such earned PB-RSUs vested on May 3, 2022. F4 · derivative.expiration_date: Performance-based restricted stock units ("PB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The PB-RSUs are eligible to be earned in equal annual amounts over a three year period based on Unisys Corporation's relative total shareholder return compared to the Russell 2000 Index from January 1, 2021 through December 31, 2021, 2022 and 2023, respectively, and then such PB-RSUs vest on the later of May 3, 2021, 2022 and 2023, respectively (or is such date does not fall on a trading day, the immediately preceding trading day), and the date on which the Board of Directors verifies the vesting of the applicable tranche of the PB-RSU grant to Unisys Corporation's Chief Executive Officer. This report only relates to the PB-RSUs the reporting person earned during the 2021 performance period. All shares resulting from such earned PB-RSUs vested on May 3, 2022. Read SEC document |
| May 03, 2022 Filed May 5, 2022 13:45 UTC | UNISYS CORP UIS · Entity 6360 | Exercise / conversionRestricted Stock Units · Derivative | 1,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-22-000030 · primary_doc.xml · derivative · entry 5 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,674 Underlying: Common Stock · 1,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Unisys Corporation common stock. F2 · derivative.exercise_date: Time-based restricted stock units ("TB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on May 3, 2022, 2023 and 2024, respectively (or is such date does not fall on a trading day, the immediately preceding trading day). F2 · derivative.expiration_date: Time-based restricted stock units ("TB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on May 3, 2022, 2023 and 2024, respectively (or is such date does not fall on a trading day, the immediately preceding trading day). Read SEC document |
| May 03, 2022 Filed May 5, 2022 13:45 UTC | UNISYS CORP UIS · Entity 6360 | Tax withholdingCommon Stock | 292 | $13.54 | $3,953.68 |
DisclosureSEC source: 0001857647-22-000030 · primary_doc.xml · nonDerivative · entry 4 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,922 Read SEC document |
| May 03, 2022 Filed May 5, 2022 13:45 UTC | UNISYS CORP UIS · Entity 6360 | Exercise / conversionCommon Stock | 1,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-22-000030 · primary_doc.xml · nonDerivative · entry 3 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2022 Filed May 5, 2022 13:45 UTC | UNISYS CORP UIS · Entity 6360 | Tax withholdingCommon Stock | 325 | $13.54 | $4,400.50 |
DisclosureSEC source: 0001857647-22-000030 · primary_doc.xml · nonDerivative · entry 2 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,011 Read SEC document |
| May 03, 2022 Filed May 5, 2022 13:45 UTC | UNISYS CORP UIS · Entity 6360 | Exercise / conversionCommon Stock | 1,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-22-000030 · primary_doc.xml · nonDerivative · entry 1 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 19:51 UTC | UNISYS CORP UIS · Entity 6360 | GrantRestricted Stock Units · Derivative | 5,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-22-000016 · primary_doc.xml · derivative · entry 1 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,742 Underlying: Common Stock · 5,742 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Unisys Corporation common stock. F2 · derivative.exercise_date: Time-based restricted stock units ("TB-RSUs") granted on February 25, 2022 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on February 25, 2023, 2024 and 2025, respectively (or if such date does not fall on a trading day, the immediately preceding trading day). F2 · derivative.expiration_date: Time-based restricted stock units ("TB-RSUs") granted on February 25, 2022 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on February 25, 2023, 2024 and 2025, respectively (or if such date does not fall on a trading day, the immediately preceding trading day). Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 02:19 UTC | UNISYS CORP UIS · Entity 6360 | GrantRestricted Stock Units · Derivative | 1,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-22-000001 · primary_doc.xml · derivative · entry 1 Allen Dwayne · CIK 0001857647 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,202 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 0.9000 shares of Unisys Corporation common stock. F2 · derivative.exercise_date: Performance-based restricted stock units ("PB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The PB-RSUs are eligible to be earned in equal annual amounts over a three year period based on Unisys Corporation's relative total shareholder return compared to the Russell 2000 Index from January 1, 2021 through December 31, 2021, 2022 and 2023, respectively, and then such PB-RSUs would vest on May 3, 2022, 2023 and 2024, respectively. This report only relates to the PB-RSUs the reporting person earned during the 2021 performance period. All shares resulting from such earned PB-RSUs will vest on May 3, 2022. F2 · derivative.expiration_date: Performance-based restricted stock units ("PB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The PB-RSUs are eligible to be earned in equal annual amounts over a three year period based on Unisys Corporation's relative total shareholder return compared to the Russell 2000 Index from January 1, 2021 through December 31, 2021, 2022 and 2023, respectively, and then such PB-RSUs would vest on May 3, 2022, 2023 and 2024, respectively. This report only relates to the PB-RSUs the reporting person earned during the 2021 performance period. All shares resulting from such earned PB-RSUs will vest on May 3, 2022. Read SEC document |
| May 03, 2021 Filed May 4, 2021 22:12 UTC | UNISYS CORP UIS · Entity 6360 | GrantRestricted Stock Units · Derivative | 8,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-21-000002 · primary_doc.xml · derivative · entry 3 Allen Dwayne · CIK 0001857647 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,955 Underlying: Common Stock · 8,955 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive up to one share of Unisys Corporation common stock. F6 · derivative.exercise_date: Performance-based restricted stock units ("PB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The PB-RSUs vest at a conversion rate of between 0.5 shares to 1 share of Unisys Corporation common stock for each PB-RSU if the 20-trading day trailing average of the closing price of Unisys Corporation's common stock over any 20 consecutive trading days during the period from the grant date through May 3, 2024 is 10% to 20% higher (with the conversion rate determined by linear interpolation for increases between such range) than the average closing price of the common stock over the 20 consecutive trading day period up to and including the grant date. If this test is not met at least at the 10% level, then the PB-RSUs will not vest at all. If this test is met at greater than the 20% level, then the PB-RSUs will vest at the rate of 1 share of common stock for each PB-RSU. F6 · derivative.expiration_date: Performance-based restricted stock units ("PB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The PB-RSUs vest at a conversion rate of between 0.5 shares to 1 share of Unisys Corporation common stock for each PB-RSU if the 20-trading day trailing average of the closing price of Unisys Corporation's common stock over any 20 consecutive trading days during the period from the grant date through May 3, 2024 is 10% to 20% higher (with the conversion rate determined by linear interpolation for increases between such range) than the average closing price of the common stock over the 20 consecutive trading day period up to and including the grant date. If this test is not met at least at the 10% level, then the PB-RSUs will not vest at all. If this test is met at greater than the 20% level, then the PB-RSUs will vest at the rate of 1 share of common stock for each PB-RSU. Read SEC document |
| May 03, 2021 Filed May 4, 2021 22:12 UTC | UNISYS CORP UIS · Entity 6360 | GrantRestricted Stock Units · Derivative | 4,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-21-000002 · primary_doc.xml · derivative · entry 2 Allen Dwayne · CIK 0001857647 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,478 Underlying: Common Stock · 4,478 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Unisys Corporation common stock. F4 · derivative.exercise_date: Time-based restricted stock units ("TB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest on May 3, 2024. F4 · derivative.expiration_date: Time-based restricted stock units ("TB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest on May 3, 2024. Read SEC document |
| May 03, 2021 Filed May 4, 2021 22:12 UTC | UNISYS CORP UIS · Entity 6360 | GrantRestricted Stock Units · Derivative | 4,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001857647-21-000002 · primary_doc.xml · derivative · entry 1 Allen Dwayne · CIK 0001857647 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,010 Underlying: Common Stock · 4,010 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Unisys Corporation common stock. F2 · derivative.exercise_date: Time-based restricted stock units ("TB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on May 3, 2022, 2023, and 2024 respectively (or if such date does not fall on a trading day, the immediately preceding trading day). F2 · derivative.expiration_date: Time-based restricted stock units ("TB-RSUs") granted on May 3, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on May 3, 2022, 2023, and 2024 respectively (or if such date does not fall on a trading day, the immediately preceding trading day). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.